PubMed Health⌕ Search

Biomedical subjects

G Iacob

Publications and source records attributed to G Iacob.

16 recordsLinked to original sources
PubMed2004

Ten years of cyclosporine use in renal transplantation: a single-center experience with 479 renal transplants.

INTRODUCTION: From 1983 to 1996 therapy with cyclosporine in association with low-dose azathioprine and prednisone has been used for transplantation immunosuppression. The aim of our study was to present 10 years experience with cyclosporine. MATERIAL AND METHOD: Among 479 renal transplants performed since 1992, 61 were performed with cadaver donor grafts and 58 in pediatric recipients. From 1992 to 1998, the immunosuppressive protocol included CsA, azathioprine, and prednisone. Since 1998, mycophenolate mofetil (MMF) replaced azathioprine. In 2002, tacrolimus and rapamycin were introduced into our protocols. The patients were assessed in terms of serum creatinine, incidence of acute rejection, cyclosporine side effects, and graft and patient survivals. RESULTS: Five-year patient and graft survivals were higher among recipients receiving CsA-MMF-prednisone when compared with CsA-azathioprine-prednisone. The incidence of acute rejection episodes during the first year after transplantation was less frequent among recipients receiving MMF compared to those treated with azathioprine. The overall 5-year survivals for patients was 86.29% and for grafts 74.04%. CONCLUSION: Cyclosporine remains a useful immunosuppressive drug, which represents a major step toward efficient renal transplantation. The availability of multiple effective immunosuppressive agents allows individualized protocols to reduce toxic effects. The advent of new induction regimens offers more opportunities to prolong graft life.

Adult↗
PubMedDate not supplied

[The outlook for human blood component separation and the treatment of cancerous tumors by magnetic methods].

This work presents in brief some expectations related to the solution of certain biomedical problems by using a non-conventional physical method: The high-gradient magnetic separation (HGMS). At first a short presentation of the HGMS method is given and then its application in separation of the human blood components is reported. The up to date intensely studied method with magnetic carriers is then described. Among other things, this method enables the cancer tumors treatment by intracavity radiotherapy, drug targeting, and diagnosis exploration.

Blood Component Removal↗
PubMedDate not supplied

[The use of high gradient magnetic separation (HGMS) in obtaining red blood cell mass].

This paper presents the "high gradient magnetic separation" (HGMS) and its use in red blood cells separation. A high gradient magnetic field system is described (set up from a filamentary iron-magnetic matrix), that is specially design for red blood cells capture. The configurations and the conditions that are needed for the red blood cells concentration process to allow the red blood cells mass to by obtained are evaluated. Finally, another possible technique of red blood cells concentration based on a type of continual magnetic separation is described.

Cell Separation↗
PubMedDate not supplied

[Actual modalities of separation by magnetic methods of active biological compounds, cells and pathogenic agents].

The paper presents an overview on magnetic techniques of bio-processing and some of their possible applications. These techniques are in fact direct, or more frequently, indirect magnetic means for separation of particulate substances. A brief presentation of direct and of the most important indirect methods (magnetic carrier and magnetic fluids technologies) is made. There are shown some of the possible applications of magnetic bio-processing in bio-technology and medicine: active biological compounds fixation, isolation and modification, cells and cells organelles separation, removal of xenobiotics, immuno-magnetic testing, pathogen microbes identification.

Humans↗
PubMedDate not supplied

[Magnetic carrier method- an expectation for antitumoral therapy].

In order to enhance antineoplastic agents efficiency new therapy methods were developed one of which being magnetic targeted chemotherapy (MTC). MTC method consists in a permanent or reversible selective binding of highly magnetic particles (carriers) with drugs, antibodies et. al., followed by targeting or adhesion of these complexes to the tumor using an external magnetic field. At this early stage of targeting tumors with magnetic particles, there are reasons to be optimistic.

Antineoplastic Agents↗
PubMedDate not supplied

[Laparoscopic radical cystectomy with enteric urinary diversion. Alternative to open cystectomy?].

Radical cystectomy is the standard therapy for invasive bladder cancer, with best oncological results compared to any other therapeutic alternative. Even if laparoscopic radical cystectomy (LRC) is a well established surgical procedure, performing the urinary diversion completely intracorporeal, is still a challenge due to technical difficulties and associated complications. The aim of our study is to present the first series of LRC with ureterosigmoidostomy. Since May 2004 were performed 7 LRC (5 males and 2 females) (Gr. A). All cases were T2N0 clinical stage. These patients were compared with a retrospective group of 50 patients who underwent open procedure (Gr. B) in term of: operative time, blood loss, analgesic requirements, and hospital stay. LRC has a longer operative time but with statistically significant lower blood loss, less analgesia, and shorter hospital stay. The resection margins of the surgical specimens were tumor free at pathologic examination. Long-term follow-up is pending. On short-term, the results of laparoscopic radical cystectomy are encouraging. When significant experience in laparoscopic surgery is lacking, surgeons should exercise caution with completely intracorporeal urinary diversion.

Adult↗
PubMedDate not supplied

[Preliminary pharmacological study on a "magnetic" drug complex].

Standard therapy requires high amounts of drugs, with subsequent risks of harmful effects on normal tissues. A treatment method that possible can avoid these risks is based on magnetic carriers (the method is designated also as magnetic carrier technique). The method consists in the selective attachment on a micro particle (permanent or reversible bonds), with strong magnetic moment, of an entity with no intrinsic magnetic properties (cells, microorganisms, antibody, antigens or chemicals), followed by external magnetic field targeting of the complexes ("active targeting"). The aims of this study were (1) to evaluate the acute toxicity of two original ferro-fluid (ammonium oleate and sodium oleate-based ferro-fluid) and (2) to assess the diclofenac (non-steroidal antiinflammatory drug, NSAIDS)--sodium oleate-based ferro-fluid efficiency in an acute inflammation model. We founded ammonium oleate-based ferro-fluid to have a strong dose-dependent toxicity, possible trough in vivo ammonium ions release; sodium oleate based-ferro-fluid seems to have a less toxicity. Diclofenac, diclofenac-ferro-fluid complex and ferro-fluid alone, each blocks the 6 hours inflammatory peak and the first two block also the 72 hours inflammatory peak. We conclude that the diclofenac-ferro-fluid complex is probably concentrated in the area of external magnetic field application, leading to a stronger effect of the antiinflammatory drug. Taking in consider our results we cannot exclude a possible summation of the individual effects of diclofenac, ferro-fluid, and external magnetic field on the inflammatory phenomenon.

Animals↗
PubMedDate not supplied

[Functional dyspepsia in liver cirrhosis].

Many patients with liver cirrhosis have dyspeptic complaints. Peptic ulcer, gallstones and oesophagitis are the most common causes of dyspepsia. Functional dyspepsia is infrequently investigated in liver cirrhosis. Sixty-two patients with liver cirrhosis and dyspepsia were submitted to endoscopic and sonographic investigation. In 28 of them no organic finding was detected. These cases were considered as having functional dyspepsia. 36% were of dysmotility-like type, 28% were ulcer- and reflux-like, each, and 7% were of idiopathic type. Aerophagia could not be taken in consideration as functional dyspepsia, due to portal hypertension. In comparison with a group of 30 patients with functional dyspepsia without liver cirrhosis, functional dyspepsia in liver cirrhosis is more frequent in men than in women and occurs about a decade later. In 12 subjects the gastric emptying of a semifluid meal estimated by sonography was normal. Functional dyspepsia is a reality in liver cirrhosis. Gastric emptying seems not to have a major role in the etiopathogenesis of such complaints.

Aged↗